{
    "clinical_study": {
        "@rank": "50189", 
        "acronym": "ETOS", 
        "arm_group": [
            {
                "arm_group_label": "Probiotic", 
                "arm_group_type": "Active Comparator", 
                "description": "Probiotic VSL#3 for 15 weeks, dosage variations according to the weight"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "subjects treated with placebo for 15 weeks"
            }
        ], 
        "brief_summary": {
            "textblock": "The aim of the study is:\n\n        -  Epidemiological/observational: investigating the presence of neuropsychological and\n           electrophysiological alterations, suggesting a condition of minimal hepatic\n           encephalopathy(and its behavioral correlates), in childhood and young adulthood\n           affected by pre-hepatic portal hypertension due to portal vein thrombosis, even for\n           implementing specific diagnostic protocols.\n\n        -  Interventional: collecting preliminary data on the effects of a probiotic, in order to\n           implement a controlled clinical study."
        }, 
        "brief_title": "ETOS: Minimal Hepatic Encephalopathy in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hepatic Encephalopathy", 
        "condition_browse": {
            "mesh_term": [
                "Hepatic Encephalopathy", 
                "Hypertension", 
                "Hypertension, Portal", 
                "Brain Damage, Chronic", 
                "Delirium", 
                "Encephalitis", 
                "Neurotoxicity Syndromes"
            ]
        }, 
        "detailed_description": {
            "textblock": "Epidemiological/observational study investigating the presence of neuropsychological and\n      electrophysiological alterations, suggesting a condition of minimal hepatic\n      encephalopathy(and its behavioral correlates), in childhood and young adulthood affected by\n      pre-hepatic portal hypertension due to portal vein thrombosis, even for implementing\n      specific diagnostic protocols"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  extra-hepatic portal vein thrombosis\n\n          -  4-20 years\n\n          -  knowledge of italian language\n\n          -  absence of perceptive or communicative deficit\n\n          -  absence of psychiatric disease or mental retardation\n\n        Exclusion Criteria:\n\n          -  medical contraindications for required evaluations\n\n          -  infective pathologies\n\n          -  parenchymal hepatic pathologies"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "20 Years", 
            "minimum_age": "4 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01798329", 
            "org_study_id": "ETOS"
        }, 
        "intervention": {
            "arm_group_label": "Probiotic", 
            "description": "VSL#3 is a probiotic that reduces:\nurease faecal activity\nfaecal pH\ninflammatory cytokine", 
            "intervention_name": "probiotic VSL#3", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Minimal Hepatic Encephalopathy", 
            "Pre-hepatic Portal Hypertension", 
            "portal vein thrombosis"
        ], 
        "lastchanged_date": "February 21, 2013", 
        "location": [
            {
                "contact": {
                    "email": "ldantiga@hpg23.it", 
                    "last_name": "Lorenzo D'Antiga, MD", 
                    "phone": "+39 0352673856"
                }, 
                "facility": {
                    "address": {
                        "city": "Bergamo", 
                        "country": "Italy", 
                        "zip": "24127"
                    }, 
                    "name": "Azienda Ospedaliera Papa Giovanni XXIII"
                }, 
                "investigator": [
                    {
                        "last_name": "LORENZO D'ANTIGA, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "MICHELA BRAVI, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "VALERIA CASOTTI, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "MARA COLUSSO, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "MARCO PEZZANI, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "LORELLA CAFFI, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "EMILIO UBIALI, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "MARIA SIMONETTA SPADA, PSYCHOLOGIST", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "AVE MARIA BIFFI, PSYCHOLOGIST", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "SILVIA BULLA, PSYCHOLOGIST", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "PAOLA PREVITALI, PSYCHOLOGIST", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "VERONICA FACCHINETTI, PSYCHOLOGIST", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "CRISTINA MORO, PSYCHOLOGIST", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Padova", 
                        "country": "Italy"
                    }, 
                    "name": "University of Padua"
                }, 
                "status": "Active, not recruiting"
            }
        ], 
        "location_countries": {
            "country": "Italy"
        }, 
        "number_of_arms": "2", 
        "official_title": "Minimal Hepatic Encephalopathy in Pre-hepatic Portal Hypertension Due to Portal Vein Thrombosis in Childhood and Young Adult: epidemiOlogical Study and Pilot Interventional Study.", 
        "overall_contact": {
            "email": "ldantiga@hpg23.it", 
            "last_name": "Lorenzo D'Antiga, MD", 
            "phone": "+39 0352673856"
        }, 
        "overall_contact_backup": {
            "email": "abiffi@hpg23.it", 
            "last_name": "Ave Maria Biffi, psychologist", 
            "phone": "+39 0352674482"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Italy: National Bioethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Improvement in the spectrum of the digitalised electroencephalogram, improvement in the performance of the psychometric tests", 
            "measure": "neuropsychological and electrophysiological aspects", 
            "safety_issue": "No", 
            "time_frame": "after 15 weeks of probiotic or placebo treatment"
        }, 
        "reference": [
            {
                "PMID": "15554421", 
                "citation": "Amodio P, Montagnese S, Gatta A, Morgan MY. Characteristics of minimal hepatic encephalopathy. Metab Brain Dis. 2004 Dec;19(3-4):253-67. Review."
            }, 
            {
                "PMID": "18602716", 
                "citation": "Amodio P, Campagna F, Olianas S, Iannizzi P, Mapelli D, Penzo M, Angeli P, Gatta A. Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study. J Hepatol. 2008 Sep;49(3):346-53. doi: 10.1016/j.jhep.2008.04.022. Epub 2008 Jun 2."
            }, 
            {
                "PMID": "10454268", 
                "citation": "Amodio P, Marchetti P, Del Piccolo F, de Tourtchaninoff M, Varghese P, Zuliani C, Campo G, Gatta A, Gu\u00e9rit JM. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol. 1999 Aug;110(8):1334-44."
            }, 
            {
                "PMID": "10347105", 
                "citation": "Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A. Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology. 1999 Jun;29(6):1662-7."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01798329"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ospedali Riuniti di Bergamo", 
            "investigator_full_name": "Dr. Lorenzo D'Antiga", 
            "investigator_title": "MD, Director of Pediatric Unit", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Decreased level of serum ammonia", 
                "measure": "biochemical blood test", 
                "safety_issue": "No", 
                "time_frame": "after 15 weeks of probiotic or placebo treatment"
            }, 
            {
                "measure": "urine and faeces analysis", 
                "safety_issue": "No", 
                "time_frame": "after 15 weeks of probiotic or placebo treatment"
            }, 
            {
                "measure": "abdomen scan with color doppler technique", 
                "safety_issue": "No", 
                "time_frame": "after 15 weeks of probiotic or placebo treatment"
            }, 
            {
                "measure": "neurological evaluation", 
                "safety_issue": "No", 
                "time_frame": "after 15 weeks of probiotic or placebo treatment"
            }, 
            {
                "measure": "dietary anamnesis (last three days)", 
                "safety_issue": "No", 
                "time_frame": "after 15 weeks of probiotic or placebo treatment"
            }, 
            {
                "measure": "bowel frequency and characteristics", 
                "safety_issue": "No", 
                "time_frame": "after 15 weeks of probiotic or placebo treatment"
            }
        ], 
        "source": "A.O. Ospedale Papa Giovanni XXIII", 
        "sponsors": {
            "collaborator": {
                "agency": "University of Padua", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "A.O. Ospedale Papa Giovanni XXIII", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}